BlackRock Fund Advisors - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$8,000
-11.1%
56,586
+28.1%
0.00%
Q3 2016$9,000
-10.0%
44,166
+11.7%
0.00%
Q2 2016$10,000
-16.7%
39,543
+8.0%
0.00%
Q1 2016$12,000
+9.1%
36,599
+24.0%
0.00%
Q4 2015$11,00029,5150.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$54,0000.03%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 200,000$73,0000.02%
Benin Management CORP 83,000$30,0000.02%
TWO SIGMA SECURITIES, LLC 36,129$13,0000.02%
NIXON PEABODY TRUST CO 10,000$4,0000.00%
Advisory Services Network, LLC 23,000$8,0000.00%
Sheaff Brock Investment Advisors, LLC 69,500$25,0000.00%
First Heartland Consultants, Inc. 21,500$8,0000.00%
INVESTMENT CENTERS OF AMERICA INC 10,000$4,0000.00%
Renaissance Technologies 1,266,400$460,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders